Research and Development
27 September 2017
Pharmaceutical Specialist, Biologics – Pharmaceutical Development & Manufacturing
Would you like to be a part of setting the strategic direction within formulation development on key biologics projects? Do you possess a creative mind-set and strategic skills? Do you enjoy solving complex scientific challenges in an environment where prerequisites and timelines may change overnight? Then you may be our new Pharmaceutical Specialist within Biologics.
In Pharmaceutical Development & Manufacturing we are 17 highly skilled and passionate colleagues who are focused on pharmaceutical development of all clinical and commercial formulations from early phase development to commercial implementation and life cycle management. The department works with both small molecules and biologics. As a part of our new strategy we have an increased focus on biologics in the CMC area and an important part of this new position is to provide scientific and strategic leadership for pharmaceutical development activities in support of our biologics pipeline (mAbs), spanning pre-IND stage through validation and launch.
The department is part of Chemical and Pharmaceutical Research (CMC development) located in Valby. Our focus in CPR is to support the development of new drug candidates within depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease. We strive to develop new innovating treatments to help improve the lives of the patients suffering from these diseases.
The ideal candidate is an experienced Pharmaceutical Specialist with experience with biologics. You will enjoy playing a key role in applying scientific knowledge and expertise to propose new areas to explore and expand our scientific know-how. You will work with a wide variety of exciting activities in close collaboration with colleagues in your team and across the organization from Research to production. You will also play an important role in the collaboration and expectation management with our CRO’s and CMO’s as most activities for biologics are currently outsourced.
Your job and key responsibilities
You will be responsible for development of pharmaceutical formulations and processes to support our global development projects, with primary focus on the biologics projects.
You will be an active part of the CMC project team, where your main tasks will include:
Our preferred candidate has the following personal and professional qualifications:
For further information, please contact Senior Director of Pharmaceutical R&D Frank Høien Lendal on FHK@lundbeck.com or + 45 30 83 23 99 or Director of Pharmaceutical Development & Manufacturing Kirstine Høeg-Møller on KIRB@lundbeck.com or +45 30 83 35 98.
Your application and CV should not be sent via email.
We also recommend that you have a look at our website.
Please click on the link below to apply for the job. Applications must be received no later than 27 09 2017.
Lundbeck is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.
An estimated 700 million people worldwide are living with psychiatric and neurological disorders and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with psychiatric and neurological disorders – we call this Progress in Mind.
Read more at http://www.lundbeck.com/global/about-us/progress-in-mind.
Our approximately 5,300 employees in 55 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have research centres in China and Denmark and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of DKK 14.6 billion in 2015 (EUR 2 billion; USD 2.2 billion).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck .
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders.
Become part of Lundbeck's professional network to stay up-to-date with our worldwide career opportunities.Go to LinkedIn
Stay updated with the latest news and conversations around Lundbeck and our business.Go to Twitter
Learn about our disease areas and hear stories by patients living with psychiatric and neurological disorders.Go to YouTube